Peter Nash - Dissemin

Papers authored by Peter Nash

This paper is made freely available by the publisher.

2018 Mark C. Genovese, César Pacheco-Tena, Arturo Covarrubias, Gustavo Leon, Eduardo Mysler, Mauro Keiserman, Robert M. Valente, Peter Nash

, J. Abraham Simon-Campos, Jane Box, Clarence W. Legerton, Evgeny Nasonov, Patrick Durez, Ayanbola Elegbe, Robert Wong and 3 other authors

Longterm Safety and Efficacy of Subcutaneous Abatacept in Patients with Rheumatoid Arthritis: 5-year Results from a Phase IIIb Trial

Download from www.jrheum.org

Peter Nash

, Iain B. McInnes, Philip J. Mease, Howard Thom, Matthias Hunger, Andreas Karabis, Kunal Gandhi, Shephard Mpofu, Steffen M. Jugl

Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison

Download from link.springer.com

This paper was not found in any repository, but could be made available legally by the author.

Laura C. Coates

, Oliver FitzGerald

, Joseph F. Merola, Josef Smolen, Leonieke J. J. van Mens, Heidi Bertheussen, Wolf-Henning Boehncke, Kristina Callis Duffin, Willemina Campbell, Maarten de Wit, Dafna Gladman, Alice Gottlieb, Jana James, Arthur Kavanaugh, Lars Erik Kristensen and 11 other authors

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic Arthritis

Upload

Peter Nash

, Kamal Ohson, Jessica Walsh, Nikolay Delev, Dianne Nguyen, Lichen Teng, Juan J. Gómez-Reino, Jacob A. Aelion

Early and sustained efficacy with apremilast monotherapy in biological-naïve patients with psoriatic arthritis: a phase IIIB, randomised controlled trial (ACTIVE)

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Walter P. Maksymowych, Vibeke Strand, Peter Nash

, Yusuf Yazici, Howard Thom, Matthias Hunger, Chrysostomos Kalyvas, Kunal K. Gandhi, Brian Porter, Steffen M. Jugl

Comparative effectiveness of secukinumab and adalimumab in ankylosing spondylitis as assessed by matching-adjusted indirect comparison

Upload

Peter Nash

, Philip J. Mease, Iain B. McInnes, Proton Rahman, Christopher T. Ritchlin, Ricardo Blanco, Eva Dokoupilova, Mats Andersson, Radhika Kajekar, Shephard Mpofu, 3. Study Group Future, Luminita Pricop, Future study Group

Efficacy and safety of secukinumab administration by autoinjector in patients with psoriatic arthritis: results from a randomized, placebo-controlled trial (FUTURE 3)

Download from link.springer.com

Distributing this paper is prohibited by the publisher

2017 Christina Charles-Schoeman, Désirée van der Heijde, Gerd R. Burmester, Peter Nash

, Cristiano A. F. Zerbini, Carol A. Connell, Haiyun Fan, Kenneth Kwok, Eustratios Bananis, Roy Fleischmann

Effect of Glucocorticoids on the Clinical and Radiographic Efficacy of Tofacitinib in Patients with Rheumatoid Arthritis: A Posthoc Analysis of Data from 6 Phase III Studies

Upload

Laura C. Coates

, Philip G. Conaghan, Maria Antonietta D’Agostino, Maarten De Wit, Oliver FitzGerald

, Tore K. Kvien, Rik Lories

, Philip Mease, Peter Nash

, Georg Schett, Enrique R. Soriano, Paul Emery

Remission in psoriatic arthritis—where are we now?

Upload

Gerd R. Burmester, Gurjit S. Kaeley, Arthur F. Kavanaugh, Cem Gabay, Daryl K. MacCarter, Peter Nash

, Tsutomu Takeuchi, Sandra L. Goss, Ramona Rodila, Kun Chen, Hartmut Kupper, Jasmina Kalabic

Treatment efficacy and methotrexate-related toxicity in patients with rheumatoid arthritis receiving methotrexate in combination with adalimumab

Download from doi.org

Somnath Bandyopadhyay

, Sean E. Connolly, Omar Jabado, June Ye, Sheila Kelly, Michael A. Maldonado, Rene Westhovens, Peter Nash

, Joan T. Merrill, Robert M. Townsend

Identification of biomarkers of response to abatacept in patients with SLE using deconvolution of whole blood transcriptomic data from a phase IIb clinical trial

Download from doi.org

Peter Nash

, Bruce Kirkham, Masato Okada, Proton Rahman, Benard Combe, Gerd-Ruediger Burmester, David H. Adams, Lisa Kerr, Chin Lee, Catherine L. Shuler, Mark Genovese, Khalid Ahmed, Jeffrey Alper, Nichol Barkham, Ralph E. Bennett and 68 other authors

Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial

Upload

Marc Egeth

, Jennifer Soosaar, Peter Nash

, Denis Choquette, Ricardo Infante, Dena Rosen Ramey, Sevag Sahakian, Angela Lai, Jin Ju Kim, David Wu

Patient and Healthcare Professionals Preference for Brenzys vs. Enbrel Autoinjector for Rheumatoid Arthritis: A Randomized Crossover Simulated-Use Study

Download from link.springer.com

Graeme Jones, Peter Nash

, Stephen Hall

Advances in rheumatoid arthritis

Download from onlinelibrary.wiley.com

Stanley B. Cohen, Yoshiya Tanaka, Xavier Mariette, Jeffrey R. Curtis, Eun Bong Lee, Peter Nash

, Kevin L. Winthrop, Christina Charles-Schoeman, Krishan Thirunavukkarasu, Ryan DeMasi, Jamie Geier, Kenneth Kwok, Lisy Wang, Richard Riese, Jürgen Wollenhaupt

Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials

Upload

Josef S. Smolen, Smolen Js, Robert Landewé, Ferdinand C. Breedveld, Gerd Burmester, Katerina Chatzidionysiou, Maya Buch, Maxime Dougados, Marieke Voshaar, Jackie Nam, Cécile Gaujoux-Viala, Johannes W. J. Bijlsma, Ronald van Vollenhoven, Sofia Ramiro

, Chris D. Buckley and 49 other authors

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

Download from doi.org

This paper is available in a repository.

2016 Peter Nash

, Johan Vanhoof, Stephen Hall, Udayasankar Arulmani, Rita Tarzynski-Potempa, Kristina Unnebrink, Andrew N. Payne, Alfred Cividino

Randomized Crossover Comparison of Injection Site Pain with 40 mg/0.4 or 0.8 mL Formulations of Adalimumab in Patients with Rheumatoid Arthritis

Download from doi.org

Janet E. Pope, Naomi F. Rothfield, Rosalind Ramsey‐Goldman, C. Douglas Smith, Sasha R. Bernatsky, Richard A. Furie, Marie Hudson, Ruben Burgos‐Vargas, Jean‐Luc Senécal, Murat Inanç, Ronald F. van Vollenhoven, Vinod Chandran, Peter T. Nash

, Chayawee Muangchan

Upload

Paul Emery, Roy M. Fleischmann, Ingrid Strusberg, Patrick Durez, Peter Nash

, Eric Jason B. Amante, Melvin Churchill, Won Park, Bernardo Pons‐Estel, Chenglong Han, Timothy A. Gathany, Stephen Xu, Yiying Zhou, Jocelyn H. Leu, Elizabeth C. Hsia

Efficacy and Safety of Subcutaneous Golimumab in Methotrexate‐Naive Patients With Rheumatoid Arthritis: Five‐Year Results of a Randomized Clinical Trial

Upload

Laura C. Coates, Arthur Kavanaugh, Philip J. Mease, Enrique R. Soriano, Maria Laura Acosta-Felquer, Maria Laura Acosta-Felquer, April W. Armstrong, Wilson Bautista-Molano, Wolf-Henning Boehncke, Willemina Campbell, Alberto Cauli, Luis R. Espinoza, Oliver Fitzgerald

, Dafna D. Gladman, Alice Gottlieb and 16 other authors

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis

Download from www.researchgate.net

2015 K. A. Patterson, P. J. Roberts-Thomson, S. Lester, J. A. Tan, P. Hakendorf, M. Rischmueller, J. Zochling, J. Sahhar, P. Nash

, J. Roddy, C. Hill, M. Nikpour, W. Stevens, S. M. Proudman, J. G. Walker

Interpretation of an extended autoantibody profile in a well-characterized Australian systemic sclerosis (Scleroderma) cohort using principal components analysis

Download from api.wiley.com

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

Papers authored by Peter Nash